PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 54 filers reported holding PROQR THRAPEUTICS N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,057,860 | -23.9% | 653,000 | 0.0% | 0.25% | -39.3% |
| Q1 2023 | $1,390,890 | -74.3% | 653,000 | -55.3% | 0.42% | -77.8% |
| Q4 2022 | $5,402,000 | +133.0% | 1,460,000 | -53.1% | 1.88% | +96.2% |
| Q3 2022 | $2,318,000 | +8.8% | 3,115,000 | +13.7% | 0.96% | -0.4% |
| Q2 2022 | $2,131,000 | -2.9% | 2,740,000 | +13.0% | 0.96% | +40.9% |
| Q1 2022 | $2,195,000 | -80.9% | 2,425,000 | +68.9% | 0.68% | -72.0% |
| Q4 2021 | $11,498,000 | -3.5% | 1,435,510 | +0.8% | 2.44% | +9.5% |
| Q3 2021 | $11,921,000 | +28.1% | 1,424,200 | +3.2% | 2.23% | +44.1% |
| Q2 2021 | $9,304,000 | +8.0% | 1,380,400 | +5.9% | 1.54% | +22.1% |
| Q1 2021 | $8,613,000 | – | 1,303,000 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
| Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
| RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
| Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
| Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
| COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
| Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
| APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
| ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |